window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 3, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Biopharma

  • CDMOs & Manufacturing,Movers & Shakers

    Symbiosis expands global reach with key appointment of Angelika Rublack as senior business development manager

    Symbiosis Pharmaceutical Services (Symbiosis), a global contract manufacturing organization (CMO) [...]

    June 16, 2025
  • Biologics & Biosimilars,Drug Development,Technology and platforms

    Revolutionizing omics and biopharma: Thermo Fisher Scientific’s latest instruments debut at ASMS 2025

    Thermo Fisher Scientific has unveiled a new suite of analytical [...]

    June 2, 2025
  • Regulatory Affairs,Technology and platforms

    myTomorrows unveils new SaaS platform to streamline global expanded access programs

    Health tech company myTomorrows has launched a dedicated platform to [...]

    May 28, 2025
  • Supply Chain & Logistics

    Ecolab expands US bioprocessing footprint with new applications lab in Pennsylvania

    Ecolab Life Sciences has opened a new bioprocessing applications laboratory [...]

    May 19, 2025
  • CDMOs & Manufacturing,Cell & Gene Therapy,Drug Development

    ReiThera to showcase AAV breakthroughs and expand US reach

    May 13, 2025
  • Artificial Intelligence,Drug Development

    EXCLUSIVE interview: How foundation models are redefining small molecule drug discovery

    As generative AI rapidly evolves, one of its most promising [...]

    May 5, 2025
  • CDMOs & Manufacturing,Drug Development,Partnerships & Funding

    BridgeBio sees strong launch for ATTR-CM drug Attruby and accelerates rare disease pipeline

    BridgeBio Pharma reported $36.7 million in US net revenue for [...]

    May 1, 2025
  • Cell & Gene Therapy

    Cycuria Therapeutics launches with advisory board and major grant funding

    April 28, 2025
  • Clinical Trials

    Oculis completes enrollment in DIAMOND Phase 3 trials of OCS-01 for diabetic macular edema

    June 4, 2025
  • Artificial Intelligence

    New research from eClinical Solutions highlights AI adoption and focus on risk-based strategies in 2025

    June 5, 2025
Previous12

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Levicept reports Phase 2 osteoarthritis data in The Lancet showing pain reduction with LEVI-04
    Categories: Clinical Trials, Pharmaceuticals and therapeutics, Research & Development
  • Nuclera launches GPCR nanodisc panel to address membrane protein bottleneck in drug discovery
    Categories: Biotech, Drug discovery, Research & Development, Technology and platforms
  • Ribbon CEO calls for faster adoption of AI and DNA synthesis to accelerate drug development
    Categories: Biotech, Digital Health, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top